rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2005-9-1
|
pubmed:abstractText |
Severe mania is life-threatening, carries an increased risk of suicide and has a serious impact on patients and their families. Efficient and rapid control of episodes of acute mania is needed.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0007-1250
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
187
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-34
|
pubmed:dateRevised |
2006-12-21
|
pubmed:meshHeading |
pubmed-meshheading:16135859-Acute Disease,
pubmed-meshheading:16135859-Adult,
pubmed-meshheading:16135859-Antipsychotic Agents,
pubmed-meshheading:16135859-Bipolar Disorder,
pubmed-meshheading:16135859-Double-Blind Method,
pubmed-meshheading:16135859-Female,
pubmed-meshheading:16135859-Humans,
pubmed-meshheading:16135859-Male,
pubmed-meshheading:16135859-Psychiatric Status Rating Scales,
pubmed-meshheading:16135859-Risperidone,
pubmed-meshheading:16135859-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.
|
pubmed:affiliation |
The Psychiatric Clinic, Vasant Vihar, New Delhi, India. sumantk_2002@yahoo.co.in
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|